These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25636961)

  • 1. Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.
    Powell SK; Rivera-Soto R; Gray SJ
    Discov Med; 2015 Jan; 19(102):49-57. PubMed ID: 25636961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element.
    Wang L; Wang Z; Zhang F; Zhu R; Bi J; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
    Int J Med Sci; 2016; 13(4):286-91. PubMed ID: 27076785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
    Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
    J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.
    Buck TM; Wijnholds J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer.
    Luebke AE; Foster PK; Muller CD; Peel AL
    Hum Gene Ther; 2001 May; 12(7):773-81. PubMed ID: 11339894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons.
    Choi JH; Yu NK; Baek GC; Bakes J; Seo D; Nam HJ; Baek SH; Lim CS; Lee YS; Kaang BK
    Mol Brain; 2014 Mar; 7():17. PubMed ID: 24618276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adeno-associated virus as delivery vector for gene therapy--a review.
    Lu Y
    Stem Cells Dev; 2004 Feb; 13(1):133-45. PubMed ID: 15068701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
    Saydam O; Glauser DL; Fraefel C
    Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression.
    Maina N; Zhong L; Li X; Zhao W; Han Z; Bischof D; Aslanidi G; Zolotukhin S; Weigel-Van Aken KA; Rivers AE; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2008 Apr; 19(4):365-75. PubMed ID: 18399730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector.
    Liu YL; Mingozzi F; Rodriguéz-Colôn SM; Joseph S; Dobrzynski E; Suzuki T; High KA; Herzog RW
    Hum Gene Ther; 2004 Aug; 15(8):783-92. PubMed ID: 15319035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous control of cardiac gene therapy: evidence of regulated myocardial transgene expression after adenovirus and adeno-associated virus transfer of expression cassettes containing corticosteroid response element promoters.
    Lee LY; Zhou X; Polce DR; El-Sawy T; Patel SR; Thakker GD; Narumi K; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):26-4, discussion 34-5. PubMed ID: 10384181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo.
    Ren C; Kumar S; Shaw DR; Ponnazhagan S
    Hum Gene Ther; 2005 Sep; 16(9):1047-57. PubMed ID: 16149903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adeno-associated viral vectors: methods for production and purification for gene therapy applications].
    Mena-Enriquez M; Flores-Contreras L; Armendáriz-Borunda J
    Rev Invest Clin; 2012; 64(5):487-94. PubMed ID: 23544311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus inverted terminal repeats improve neuronal transgene expression mediated by baculoviral vectors in rat brain.
    Wang CY; Wang S
    Hum Gene Ther; 2005 Oct; 16(10):1219-26. PubMed ID: 16218783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.
    Yan Z; Sun X; Feng Z; Li G; Fisher JT; Stewart ZA; Engelhardt JF
    Hum Gene Ther; 2015 Jun; 26(6):334-46. PubMed ID: 25763813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose.
    Wu Z; Sun J; Zhang T; Yin C; Yin F; Van Dyke T; Samulski RJ; Monahan PE
    Mol Ther; 2008 Feb; 16(2):280-9. PubMed ID: 18059373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 Cells.
    Strobel B; Klauser B; Hartig JS; Lamla T; Gantner F; Kreuz S
    Mol Ther; 2015 Oct; 23(10):1582-91. PubMed ID: 26137851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
    Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
    Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.